Instructions to Authors

Instructions To Author

These guidelines are in accordance with the “Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals,” published by the International Committee of Medical Journal Editors.

GENERAL INSTRUCTIONS

Text font should be Times New Roman/Arial and size should be 12. Headings should be bold. Margins should be 1֞ from all sides and text should be double spaced. Text should be submitted as MS word document.

AUTHORSHIP

As stated in the ICMJE Recommendations, credit for authorship requires (a) substantial contributions to the conception and design; or the acquisition, analysis, or interpretation of the data, (b) the drafting of the article or critical revision for important intellectual content, (c) final approval of the version to be published, and (d) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the article are appropriately investigated and resolved. Each author must sign a statement attesting that he or she fulfills the authorship criteria of the ICMJE Recommendations. As part of the submission process, authors must indicate whether any writing assistance other than copy editing was provided.

Any change in authorship after submission must be approved in writing by all authors.

ASSURANCES

In appropriate places in the manuscript, please provide the following items:

  • If applicable, a statement that the research protocol was approved by the relevant institutional review boards or ethics committees and that all human participants gave written informed consent
  • The identity of those who analyzed the data.
  • For clinical trials, the registration number and registry name.
  • For studies containing microarrays, the accession numbers and repository name.

ABSTRACT

Provide an abstract of not more than 250 words. It should consist of four paragraphs, labeled Background, Methods, Results, and Conclusions. They should briefly describe, respectively, the problem being addressed in the study, how the study was performed, the salient results, and what the authors conclude from the results.

Keywords: Three to 10 keywords or short phrases should be added to the bottom of the abstract page. Please use terms from the Medical Subject Headings (MeSH) of Index Medicus.

ORIGINAL ARTICLE

The original article should be of about 2000-2500 words excluding abstract and references. It should be structured under the following headings: Introduction, Material & Methods, Results, Discussion, Conclusions, Acknowledgements and References.

CASE REPORT

Short report of cases, clinical experience, drug trials or adverse effects may be submitted. They must not exceed 500 words, 5 bibliographic references and one table or illustration. The report must contain genuinely new information. The format is Title, Abstract, Introduction, Case Report, Discussion, and References.

Review Article, Editorial, Special Communication, Short Communication and Pictorial can also be submitted. All these should be submitted along with brief abstracts not exceeding 250 words

TABLES

For Original Articles, there is normally a limit of 5 figures and tables (total) per manuscript. Number them with Roman numerals, in the order they are mentioned in the text. Tables should be double spaced (including footnotes) and provide a brief title for each. If a table has been previously published, include written permission for its use from the copyright holder. Submit tables as text based files (word or excel)

FIGURES AND ILLUSTRATIONS

Figures should be submitted separately and must have a figure legend. The figure legend should be written at the end of the manuscript along with the figure number after references. Figures should be professionally designed. Symbols, lettering, and numbering should be clear and large enough to remain legible after the figure has been reduced to fit the width of a single column of 3 inch. Duplication of results given in tables and figures must be avoided.

PHOTOGRAPHS OF PATIENTS

If photographs of patients are used, either they should not be identifiable or the photographs should be accompanied by written permission to use them.

REFERENCES

References must be double-spaced and numbered consecutively as they are cited. References first cited in a table or figure legend should be numbered so that they will be in sequence with references cited in the text at the point where the table or figure is first mentioned. List all authors when there are six or fewer; when there are seven or more, list the first six, followed by “et al.” The following are sample references:

  1. Shapiro AMJ, Lakey JRT, Ryan EA, Korbutt GS, Toth E, Warnock GL, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000;343:230-8.
  2. Goadsby PJ. Pathophysiology of headache. In: Silberstein SD, Lipton RB, Dalessio DJ, eds. Wolff’s headache and other head pain. 7th ed. Oxford, England: Oxford University Press, 2001:57-72.
  3. Kuczmarski RJ, Ogden CL, Grammer-Strawn LM, et al. CDC growth charts: United States. Advance data from vital and health statistics. No. 314. Hyattsville, Md.: National Center for Health Statistics, 2000. (DHHS publication no. (PHS) 2000-1250 0-0431.)
  4. S. positions on selected issues at the third negotiating session of the Framework Convention on Tobacco Control. Washington, D.C.: Committee on Government Reform, 2002. (Accessed March 4, 2002, at http://www.house.gov/reform/min/inves_tobacco/index_accord.htm.)

Numbered references to personal communications, unpublished data, or manuscripts either “in preparation” or “submitted for publication” are unacceptable. If essential, such material can be incorporated at the appropriate place in the text.

STATISTICAL METHODS

  • The basis for these guidelines is described in Bailar JC III, Mosteller F. Guidelines for statistical reporting in articles for medical journals: amplifications and explanations. Ann Intern Med 1988;108:266-73.
  • For the analysis of categorical outcomes, exact methods or asymptotic methods with appropriate adjustments for small sample size should be used when the numbers of events are small. Standard chi-squared or difference in proportions tests can be used when the sample sizes and numbers of events are sufficiently large.
  • When comparing measured outcomes in two of more groups, investigators should use tests that control type I error given the apparent distributions of the measurements. For normally distributed data, t tests are appropriate, and t tests are also robust to non-normal distributions with sufficiently large sample sizes. When the sample size is small and prior evidence suggests that the measurements are unlikely to be normally distributed, appropriate nonparametric methods are usually preferable.
  • Results should be presented with only as much precision as is of scientific value. For example, measures of association, such as odds ratios, should ordinarily be reported to two significant digits.
  • Measures of uncertainty, such as confidence intervals, should be used consistently, including in figures that present aggregated results.
  • Except when one-sided tests are required by study design, such as in noninferiority trials, all reported P values should be two-sided. In general, P values larger than 0.01 should be reported to two decimal places, those between 0.01 and 0.001 to three decimal places; P values smaller than 0.001 should be reported as P<0.001. Notable exceptions to this policy include P values arising in the application of stopping rules to the analysis of clinical trials and genetic-screening studies.
  • For tables comparing treatment groups in a randomized trial (usually the first table in the trial report), significant differences between or among groups (i.e. P < 0.05) should be identified in a table footnote and the P value should be provided in the format specified in the immediately preceding paragraph. The body of the table should not include a column of P values.
  • In manuscripts that report on randomized clinical trials, authors may provide a flow diagram in CONSORT format and all of the information required by the CONSORT checklist. When restrictions on length prevent the inclusion of some of this information in the manuscript, it may be provided in a separate document submitted with the manuscript.

UNITS OF MEASUREMENT

Authors should express all measurements in conventional units, with Système International (SI) units given in parentheses throughout the text. Figures and tables should use conventional units, with conversion factors given in legends or footnotes. In accordance with the Uniform Requirements, however, manuscripts containing only SI units will not be returned for that reason.

ABBREVIATIONS

Except for units of measurement, abbreviations are strongly discouraged. Except for units of measurement, the first time an abbreviation appears, it should be preceded by the words for which it stands.

DRUG NAMES

Generic names should be used. When proprietary brands are used in research, include the brand name and the name of the manufacturer in parentheses after the first mention of the generic name in the Methods section.

CONFLICT OF INTEREST

Authors of research articles should disclose any financial arrangement they may have with a company whose product is pertinent to the submitted manuscript or with a company making a competing product.

REVIEW AND ACTION

Every paper will be read by at least two staff editors of the Editorial Board. The papers selected will then be sent to two external reviewers. The comments of reviewers are then conveyed to the corresponding author. After correction/amendments by the authors, acceptance letter for accepted article is issued, and the article is placed in queue for printing. If statistical analysis is included, further examination be a staff statistician will be carried out. The staff Bibliographer will also examine and authenticate the references and checks for plagiarism.
All authors will receive a copy of the acknowledgement e-mail and any notification of acceptance.

COPYRIGHT RELEASE

All manuscripts must be accompanied by the following written statement, signed by all authors:

“The undersigned author(s) transfer all copyright ownership of the manuscript [insert title of article here] to the AQAMC. The undersigned author(s) warrants that the article is original, does not infringe upon any copyright or other propriety right of any third party, is not under consideration by another journal, has not been previously published, and includes any product that may derive from the published journal, whether print or electronic media. I (we) sign for and accept responsibility for releasing this material.”

Scan the printed copyright release and submit via email.

CHECKLIST FOR AUTHORS

  • Cover letter
  • Title page, including full name, academic degrees, and institutional affiliation and position of each author, and author to whom correspondence and reprint requests are to be sent, including address, phone number, fax number and email address.
  • Structured abstract
  • Article, including references and figure legends
  • Figures in JPEG format
  • Tables
  • Copyright release statement, signed by all authors
  • Photograph consent statement (if applicable)
  • Conflict of interest statement
  • Permission to reproduce previously published material (where applicable)